Completed NA NCT00273195

Clinical Investigation of the Medtronic EnTrust™ Implantable Cardioverter Defibrillator (ICD), Model D153ATG

Sponsor: Medtronic Cardiac Rhythm and Heart Failure

Interventions Implantable Cardioverter Defibrillator

Updated 6 times since 2017 Last updated: Oct 11, 2006 Started: Apr 30, 2004 Completion: Jun 30, 2005

This NA trial investigates Ventricular Arrhythmias and is currently completed. Medtronic Cardiac Rhythm and Heart Failure leads this study, which shows 6 recorded versions since 2004 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.

Status Flow

Change History

6 versions recorded

Sep 2025 — Present [monthly]

Completed NA
Sep 2024 — Sep 2025 [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Completed NA

First recorded

Apr 2004

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Medtronic Cardiac Rhythm and Heart Failure

Data source: Medtronic Cardiac Rhythm and Heart Failure

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Abington, United States , Amarillo, United States , Atlantis, United States , Austin, United States , Basel, Switzerland , Bonn, Germany , Boston, United States , Calgary, Canada , Columbus, United States , Copenhagen, Denmark and 31 more locations